Screener
Arcutis Biotherapeutics, Inc. ARQT Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The source filing: Arcutis Biotherapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:21 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001787306-26-000051
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Proceeds from issuance of common stock upon exercise of stock options | 2,428 | 456 |
| Proceeds from issuance of common stock pursuant to employee stock purchase plan | 1,629 | 1,319 |
| Payment of debt prepayment penalty | (1,000) | — |
| Net cash provided by financing activities | 3,057 | 1,775 |
| Effect of exchange rate changes on cash | (165) | 204 |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | (8,786) | 1,096 |
| Cash, cash equivalents, and restricted cash at beginning of period | 43,215 | 71,952 |
| Cash, cash equivalents, and restricted cash at end of period | $34,429 | $73,048 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Arcutis Biotherapeutics, Inc.'s financing cash flow?
- Arcutis Biotherapeutics, Inc. (ARQT) reported financing cash flow of $1.99M in Q2 2026.
- How has Arcutis Biotherapeutics, Inc.'s financing cash flow changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s financing cash flow increased by 44.2% year-over-year, from $1.38M to $1.99M.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s financing cash flow?
- Over 3 years (2021 to 2025), Arcutis Biotherapeutics, Inc.'s financing cash flow has grown at a -70.9% compound annual growth rate (CAGR), from $281.95M to $6.97M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.
Ask your AI about Arcutis Biotherapeutics, Inc.'s financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude